CA2857543C - Potentiel anti-obesite de la calebine a - Google Patents

Potentiel anti-obesite de la calebine a Download PDF

Info

Publication number
CA2857543C
CA2857543C CA2857543A CA2857543A CA2857543C CA 2857543 C CA2857543 C CA 2857543C CA 2857543 A CA2857543 A CA 2857543A CA 2857543 A CA2857543 A CA 2857543A CA 2857543 C CA2857543 C CA 2857543C
Authority
CA
Canada
Prior art keywords
calebin
fat
kcal
obesity
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2857543A
Other languages
English (en)
Other versions
CA2857543A1 (fr
Inventor
Muhammed Majeed
Kalyanam Nagabhushanam
Anju Majeed
Bani Sarang
Anjali Pandey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/274,096 external-priority patent/US9328330B2/en
Application filed by Individual filed Critical Individual
Publication of CA2857543A1 publication Critical patent/CA2857543A1/fr
Application granted granted Critical
Publication of CA2857543C publication Critical patent/CA2857543C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention révèle le potentiel de la calébine A dans l'inhibition d'adipogenèse et ses applications dans la gestion de l'obésité. La présente invention élucide le potentiel de la calébine A comme modulateur favorable de marqueurs biochimiques associés à l'obésité. Les propriétés biomodulatoires notables de la calébine A comprennent l'inhibition de la production de leptine, l'augmentation de l'expression d'adiponectine et l'inhibition de l'inflammation locale (adipocyte) et ayatémique causée par les cytokines pro-inflammatoires, soit le facteur de nécrose des tumeurs (TNF-.alpha.), l'Interleukine-6 (IL-6) et l'Interleukine-1 (IL-1.beta).
CA2857543A 2014-05-09 2014-07-21 Potentiel anti-obesite de la calebine a Active CA2857543C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/274,096 US9328330B2 (en) 2011-01-10 2014-05-09 Anti-obesity potential of Calebin A
US14/274,096 2014-05-09

Publications (2)

Publication Number Publication Date
CA2857543A1 CA2857543A1 (fr) 2014-09-30
CA2857543C true CA2857543C (fr) 2015-09-29

Family

ID=51730255

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2857543A Active CA2857543C (fr) 2014-05-09 2014-07-21 Potentiel anti-obesite de la calebine a

Country Status (3)

Country Link
JP (2) JP6374716B2 (fr)
AU (1) AU2014203122B2 (fr)
CA (1) CA2857543C (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006304792A (ja) * 2005-03-31 2006-11-09 Saga Univ 内臓脂肪蓄積抑制食品
WO2010109628A1 (fr) * 2009-03-26 2010-09-30 味の素ゼネラルフーヅ株式会社 Composition pharmaceutique pour augmenter la production d'adiponectine et aliment utile pour cela
WO2013109241A1 (fr) * 2011-01-10 2013-07-25 Muhammed Majeed Potentiel anti-obésité de la calébine a
JP2012158553A (ja) * 2011-02-01 2012-08-23 Gunze Ltd 内臓脂肪蓄積抑制剤

Also Published As

Publication number Publication date
AU2014203122B2 (en) 2018-08-02
JP6374716B2 (ja) 2018-08-15
JP2017019856A (ja) 2017-01-26
JP2015214529A (ja) 2015-12-03
AU2014203122A1 (en) 2015-11-26
CA2857543A1 (fr) 2014-09-30

Similar Documents

Publication Publication Date Title
Li et al. High fat diet induced obesity model using four strains of mice: Kunming, C57BL/6, BALB/c and ICR
KR101702702B1 (ko) 칼레빈 ａ의 항-비만 가능성
Cuminetti et al. Bone marrow adipocytes: the enigmatic components of the hematopoietic stem cell niche
US9328330B2 (en) Anti-obesity potential of Calebin A
US9737502B2 (en) Calebin A for hepatic steatosis
Lee et al. D-allulose ameliorates adiposity through the AMPK-SIRT1-PGC-1α pathway in HFD-induced SD rats
CA2857543C (fr) Potentiel anti-obesite de la calebine a
CA2893321C (fr) Calebine a destinee a la steatose hepatique
JP6336943B2 (ja) 肝脂肪症用のカレビンａ
AU2012366253B2 (en) Anti-obesity potential of Calebin A
NZ708704A (en) Calebin a for hepatic steatosis
Chen et al. Nicotine induces a dual effect on the beige-like phenotype in adipocytes
NZ614076B2 (en) Anti-obesity potential of calebin a
Mortuza The Effect of Cannabidiol (CBD) on the Physiology and Immunology of Nile Tilapia (Oreochromis Niloticus) in-Vitro and in-Vivo
KR101356398B1 (ko) 대두가공 부산물을 유효성분으로 하는 비만 예방 또는 치료용 조성물
US20210220424A1 (en) Process and compositions for enhancing energy expenditure
ALAPPAT CALEBIN A ZUR BEHANDLUNG DER ENTZÜNDUNG UND DER FETTSUCHT CALEBINE A DESTINÉE AU TRAITEMENT DE L'INFLAMMATION ET DE L'OBÉSITE
Li et al. Anti-Adipogenic Effects of Complanatoside a on 3t3-L1 Adipocytes and Zabrafish